TDOC
Teladoc Health, Inc. Health Care Services-Offices & Clinics of Doctors of Medicine Russell 3000
$8.51Close
$1.5BMarket cap
$4.47 – $9.7252-week range
Jan 27, 2027Next report · estimated
Highlights
Strengths
- Leading the market RS 85 · stronger than 85% of stocks over 12 months
Cautions
- Trend not confirmed 6 of 8 conditions · 200-day not rising, 50-day under the 150/200-day
- Extended 7.1 ATR above its 50-day average
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
12%
1wk
up 34.2%
price change
1mo
up 46.7%
price change
12-month return
down 3%
market up 11% ·
its own down 7%
F-score
—
— Not assessed
Altman Z″
-16.73
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
1.1×
price / book
Earnings yield
down 35.7%
EBIT / enterprise value
Cheaper than
63%
of the market · cheap
Revenue growth
down 2%
year on year
EPS growth
—
latest quarter
Sales growth
down 3%
latest quarter · +1 pts
ROE
down 14%
return on equity
Free cash margin
up 11%
$285.5M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
5.2%
$0.44 a day · 2×ATR $7.63
RS
85 / 99
vs the universe
Trend
6 / 8
200-day not rising, 50-day under the 150/200-day
Relative volume
2.1×
vs 50-day average
Up/down volume
1.17
50 sessions
Implied move
—
no scheduled report
Trend template · 6 of 8
- 200-day average rising for a month: fails
- 50-day average above the 150 and 200-day: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Shareholders diluted The share count rose 2.8% over the year, from 173m to 178m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
- Revenue shrinking Revenue fell 1.5% over the year, from $2.6B to $2.5B.
Last reported
Oct 28, 2026
Last shock
Jul 30, 2026-28% in one session5.4× volumeon results+29% since
Financials
- Gross
- Net -8%
- Free cash 11%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $2.0B | $2.4B | $2.6B | $2.6B | $2.5B |
| Gross margin | 64% | 68% | 69% | — | — | — |
| Operating income | -$506.4M | -$265.6M | -$13.7B | -$248.6M | -$1.0B | -$263.0M |
| Net income | -$485.1M | -$428.8M | -$13.7B | -$220.4M | -$1.0B | -$200.3M |
| Net margin | -44% | -21% | -568% | -8% | -39% | -8% |
| Earnings per share | -$5.36 | -$2.73 | -$84.60 | -$1.34 | -$5.87 | -$1.14 |
| Free cash flow | -$57.5M | $185.5M | $172.8M | $338.6M | $282.9M | $285.5M |
| Free cash margin | -5% | 9% | 7% | 13% | 11% | 11% |
| Cash | $733.3M | $893.5M | $918.2M | $1.1B | $1.3B | $781.1M |
| Shareholders' equity | $15.9B | $16.0B | $2.3B | $2.3B | $1.5B | $1.4B |
| Shares outstanding | 150.28m | 160.47m | 162.84m | 166.66m | 173.41m | 178.32m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 29, 2026 | Quarterly ↗ | Sep 30, 2026 | 29d |
| Jul 30, 2026 | Quarterly ↗ | Jun 30, 2026 | 30d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Jul 30, 2025 | Quarterly ↗ | Jun 30, 2025 | 30d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| Apr 26, 2024 | Quarterly ↗ | Mar 31, 2024 | 26d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 28, 2026 | Results ↗ |
| Sep 25, 2026 | Director or officer change ↗ |
| Aug 31, 2026 | Director or officer change · Regulation FD ↗ |
| Aug 13, 2026 | Director or officer change ↗ |
| Aug 3, 2026 | Director or officer change · Regulation FD ↗ |
| Jul 29, 2026 | Results ↗ |
| May 21, 2026 | Shareholder vote ↗ |
| Apr 29, 2026 | Results ↗ |
| Mar 30, 2026 | Director or officer change · Regulation FD ↗ |
| Feb 25, 2026 | Results ↗ |
| Feb 18, 2026 | Director or officer change · Regulation FD ↗ |
| Feb 12, 2026 | Director or officer change ↗ |